SCHEMBL4988779

SCHEMBL4988779

N#Cc1ccc(S(=O)(=O)N2CCc3[c]nc(C(N)=O)nc3C2)cc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 1/20 0.45
GAA P10253 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
MAPT P10636 2/20 0.42
KDM4E B2RXH2 1/20 0.42
MEN1 O00255 1/20 0.42
KMT2A Q03164 1/20 0.42
CYP3A4 P08684 1/20 0.41
GRM5 P41594 1/20 0.41
AKR1C3 P42330 4/20 0.40
AKR1C1 Q04828 1/20 0.40
EPHX2 P34913 1/20 0.38
GBA1 P04062 2/20 0.38
PKM P14618 1/20 0.37
PKLR P30613 1/20 0.37
HSD11B1 P28845 1/20 0.37
CCR6 P51684 1/20 0.37
ALDH1A1 P00352 1/20 0.36
SCN9A Q15858 1/20 0.36
IKBKB O14920 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4988448 0.88 MEN1 (0.45) GAAMEN1KMT2AAKR1C3AKR1C1
SCHEMBL4993377 0.87 KMT2A (0.43) L3MBTL1MAPTKMT2AAKR1C3AKR1C1
SCHEMBL4988327 0.87 GBA1 (0.48) GAAMEN1KMT2AGBA1PKM
SCHEMBL4983020 0.87 MEN1 (0.47) GAAL3MBTL1KDM4EMEN1KMT2A
SCHEMBL4987925 0.84 HDAC6 (0.44) GAAL3MBTL1KDM4EMEN1KMT2A
SCHEMBL4987011 0.84 PKM (0.46) GAAL3MBTL1MAPTKDM4EMEN1
SCHEMBL4985233 0.84 TRPV4 (0.40) CYP3A4AKR1C3AKR1C1HSD11B1
SCHEMBL4980960 0.84 SMN1; SMN2 (0.46) MAPTKMT2AAKR1C3GBA1PKM
SCHEMBL4992135 0.84 ATM (0.41) TDP1GAAL3MBTL1MAPTKDM4E
SCHEMBL4986174 0.83 PKM (0.46) TDP1GAAL3MBTL1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080039478-A1 Bicycloheteroaryl Compounds as P2X7 Modulators and Uses Thereof RENOVIS, INC. 2008-02-14 US claimed
US-7297700-B2 Bicycloheteroaryl compounds as P2X7 modulators and uses thereof RENOVIS, INC. (US) 2007-11-20 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080039478-A1 Bicycloheteroaryl Compounds as P2X7 Modulators and Uses Thereof P2RX7, P2RX3, P2RX2 TDP1 2440/4885GAA 4179/4885L3MBTL1 4476/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.